Jun 22, 2026 04:10PM
Jun 22, 2026 04:10PM
Jun 17, 2026 07:30AM
Jun 17, 2026 07:30AM
Jun 3, 2026 07:30AM
Jun 3, 2026 07:30AM
May 26, 2026 07:31AM Dyne Therapeutics submits FDA application for DMD treatment
May 26, 2026 07:30AM
May 20, 2026 07:46AM
May 20, 2026 07:46AM
May 11, 2026 07:30AM
May 11, 2026 07:30AM
Apr 27, 2026 04:34PM
Apr 1, 2026 07:30AM Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy (AMCP) Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines
Mar 9, 2026 12:34PM
Mar 9, 2026 11:45AM
Mar 9, 2026 10:29AM
Mar 9, 2026 05:26AM
Mar 8, 2026 06:01PM
Mar 8, 2026 06:01PM
Mar 8, 2026 06:00PM Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)
Mar 3, 2026 07:22AM
Mar 2, 2026 05:37PM
Mar 2, 2026 02:37PM
Mar 2, 2026 07:30AM
Feb 22, 2026 04:00PM
Feb 22, 2026 04:00PM
Jan 20, 2026 07:30AM Dyne Therapeutics receives orphan drug designation in Japan for DM1 treatment
Jan 20, 2026 07:30AM
Dec 23, 2025 07:30AM
Dec 23, 2025 07:30AM
Dec 9, 2025 07:40AM
Dec 8, 2025 07:40AM
Dec 8, 2025 06:30AM
Dec 8, 2025 06:30AM Dyne Therapeutics Announces Positive Topline Results from Phase 1/2 DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)
Nov 16, 2025 03:00PM
Nov 5, 2025 04:10PM
Oct 24, 2025 08:29AM
Oct 6, 2025 06:01PM
Oct 6, 2025 06:01PM
Oct 2, 2025 04:05PM
Oct 2, 2025 04:05PM Dyne Therapeutics Appoints Brian Posner to its Board of Directors
Sep 29, 2025 08:35AM
Sep 29, 2025 08:35AM
Sep 11, 2025 08:18AM
Aug 4, 2025 08:31AM
Aug 4, 2025 07:30AM
Aug 4, 2025 07:30AM
Jul 28, 2025 04:10PM Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Jul 6, 2025 10:00AM

325,464 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All